Compile Data Set for Download or QSAR
Report error Found 334 Enz. Inhib. hit(s) with all data for entry = 11862
TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654367(Preparation of (R)-1-(2,5-difluoropyridin-3-yl)eth...)
Affinity DataEC50:  2.90nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654257(US11912686, Compound 202)
Affinity DataEC50:  5nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654252(US11912686, Compound 197)
Affinity DataEC50:  5.20nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654322(US11912686, Compound 268)
Affinity DataEC50:  7.30nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654260(US11912686, Compound 205)
Affinity DataEC50:  8.30nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654143(US11912686, Compound 88)
Affinity DataEC50:  8.60nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654371(Preparation of (R)-1-(2-chloropyridin-3-yl)ethyl (...)
Affinity DataEC50:  9.5nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654344(US11912686, Compound 290)
Affinity DataEC50:  10.9nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654140(US11912686, Compound 85)
Affinity DataEC50:  11.2nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654299(US11912686, Compound 245)
Affinity DataEC50:  11.7nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654315(US11912686, Compound 261)
Affinity DataEC50:  11.9nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654368(Preparation of (R)-1-(2-chloropyridin-3-yl)ethyl (...)
Affinity DataEC50:  12.7nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654301(US11912686, Compound 247)
Affinity DataEC50:  13nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654139(US11912686, Compound 84)
Affinity DataEC50:  14.5nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654134(US11912686, Compound 79)
Affinity DataEC50:  16nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654142(US11912686, Compound 87)
Affinity DataEC50:  16.1nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654094(US11912686, Compound 168 | US11912686, Compound 39)
Affinity DataEC50:  16.2nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654280(US11912686, Compound 225)
Affinity DataEC50:  16.3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654141(US11912686, Compound 86)
Affinity DataEC50:  16.6nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654158(US11912686, Compound 103)
Affinity DataEC50:  16.6nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654127(US11912686, Compound 72)
Affinity DataEC50:  17nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654128(US11912686, Compound 73)
Affinity DataEC50:  17.3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654264(US11912686, Compound 209)
Affinity DataEC50:  17.7nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654308(US11912686, Compound 254)
Affinity DataEC50:  18.1nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654102(US11912686, Compound 47)
Affinity DataEC50:  19.1nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654312(US11912686, Compound 258)
Affinity DataEC50:  19.3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654292(US11912686, Compound 237)
Affinity DataEC50:  19.3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654319(US11912686, Compound 265)
Affinity DataEC50:  19.5nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654137(US11912686, Compound 82)
Affinity DataEC50:  20.4nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654263(US11912686, Compound 208)
Affinity DataEC50:  21.1nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654343(US11912686, Compound 289)
Affinity DataEC50:  21.5nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654271(US11912686, Compound 216)
Affinity DataEC50:  22.4nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654384(US11912686, Compound 331)
Affinity DataEC50:  22.8nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654136(US11912686, Compound 81)
Affinity DataEC50:  22.8nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654103(US11912686, Compound 48)
Affinity DataEC50:  22.8nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654130(US11912686, Compound 75)
Affinity DataEC50:  23.4nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654316(US11912686, Compound 262)
Affinity DataEC50:  23.7nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654273(US11912686, Compound 218)
Affinity DataEC50:  24nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654132(US11912686, Compound 77)
Affinity DataEC50:  25.5nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654290(US11912686, Compound 235)
Affinity DataEC50:  26.5nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654285(US11912686, Compound 230)
Affinity DataEC50:  26.7nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654347(US11912686, Compound 293)
Affinity DataEC50:  27.3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654083(Preparation of (R)-1-(2,5-difluoropyridin-3-yl)eth...)
Affinity DataEC50:  29.1nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654074(Preparation of (R)-1-(2-chloropyridin-3-yl)ethyl(4...)
Affinity DataEC50:  29.3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654101(US11912686, Compound 46)
Affinity DataEC50:  29.7nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654302(US11912686, Compound 248)
Affinity DataEC50:  29.8nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654203(US11912686, Compound 148)
Affinity DataEC50:  30.4nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654122(US11912686, Compound 67)
Affinity DataEC50:  30.8nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654225(US11912686, Compound 170)
Affinity DataEC50:  31.8nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654218(US11912686, Compound 163)
Affinity DataEC50:  32.6nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

Displayed 1 to 50 (of 334 total ) | Next | Last >>
Jump to: